bioMérieux S.A. (EPA:BIM)
France · Delayed Price · Currency is EUR 70.65
-1.20 (-1.67%)
Jul 31, 2026, 11:41 AM CET
bioMérieux Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,991 | 4,070 | 3,980 | 3,675 | 3,589 | 3,376 | |
Revenue Growth | -1.95% | 2.26% | 8.30% | 2.38% | 6.31% | 8.27% |
Cost of Revenue | 1,751 | 1,761 | 1,765 | 1,617 | 1,580 | 1,375 |
Gross Profit | 2,240 | 2,309 | 2,215 | 2,057 | 2,009 | 2,001 |
Selling, General & Admin | 1,087 | 1,111 | 1,098 | 1,021 | 954.7 | 815.6 |
Research & Development | 515.4 | 507.4 | 491.5 | 460.1 | 446.6 | 385.8 |
Other Operating Expenses | 26 | 168.8 | 37.4 | 137.6 | 20.2 | 15.1 |
Total Operating Expenses | 1,628 | 1,787 | 1,627 | 1,618 | 1,422 | 1,217 |
Operating Income | 611.8 | 521.3 | 588.8 | 439 | 587.2 | 784.3 |
Total Non-Operating Income (Expense) | -4.9 | 4.2 | -9.4 | -1.7 | -6.6 | -10.5 |
Pretax Income | 606.9 | 525.5 | 579.4 | 437.3 | 580.6 | 773.8 |
Provision for Income Taxes | 145 | 128.8 | 154.3 | 114.5 | 140.1 | 175.6 |
Net Income | 462.1 | 396.9 | 425.1 | 322.8 | 440.5 | 598.2 |
Minority Interest in Earnings | -0.5 | -0.6 | -7.1 | -34.8 | -11.8 | -2.9 |
Net Income to Common | 462.6 | 397.5 | 432.2 | 357.6 | 452.4 | 601.1 |
Net Income Growth | 16.38% | -8.03% | 20.86% | -20.95% | -24.74% | 48.64% |
Shares Outstanding (Basic) | 118 | 118 | 118 | 118 | 118 | 118 |
Shares Outstanding (Diluted) | 119 | 119 | 119 | 119 | 118 | 119 |
Shares Change | -0.23% | 0.06% | -0.03% | 0.31% | -0.38% | 0.20% |
EPS (Basic) | 3.93 | 3.37 | 3.67 | 3.03 | 3.84 | 5.08 |
EPS (Diluted) | 3.90 | 3.34 | 3.64 | 3.01 | 3.82 | 5.06 |
EPS Growth | 16.77% | -8.24% | 20.93% | -21.20% | -24.51% | 48.39% |
Free Cash Flow | 583 | 453.1 | 321.5 | 107.1 | 188.4 | 534.6 |
Free Cash Flow Growth | 28.67% | 40.93% | 200.19% | -43.15% | -64.76% | 75.11% |
Free Cash Flow Per Share | 4.92 | 3.81 | 2.71 | 0.90 | 1.59 | 4.50 |
Dividends Per Share | 0.980 | 0.980 | 0.900 | 0.850 | 0.850 | 0.850 |
Dividend Growth | 0% | 8.89% | 5.88% | 0% | 0% | 37.10% |
Gross Margin | 56.13% | 56.73% | 55.66% | 55.99% | 55.97% | 59.26% |
Operating Margin | 15.33% | 12.81% | 14.79% | 11.95% | 16.36% | 23.23% |
Profit Margin | 11.58% | 9.75% | 10.68% | 8.78% | 12.27% | 17.72% |
FCF Margin | 14.61% | 11.13% | 8.08% | 2.91% | 5.25% | 15.83% |
EBITDA | 1,067 | 959.7 | 913.9 | 827.5 | 864.2 | 1,032 |
EBITDA Margin | 26.74% | 23.58% | 22.96% | 22.52% | 24.08% | 30.57% |
EBIT | 611.8 | 521.3 | 588.8 | 439 | 587.2 | 784.3 |
EBIT Margin | 15.33% | 12.81% | 14.79% | 11.95% | 16.36% | 23.23% |
Effective Tax Rate | 23.89% | 24.51% | 26.63% | 26.18% | 24.13% | 22.69% |